Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 11.93 Billion | USD 17.32 Billion | 3.8% | 2024 |
FrequentlyAsked Questions
The global general anxiety disorder treatment market is expected to grow due to increasing prevalence of anxiety disorders, rising mental health awareness, advancements in pharmacological and therapeutic treatments, and growing adoption of digital mental health solutions.
According to a study, the global general anxiety disorder treatment market size was worth around USD 11.93 Billion in 2024 and is expected to reach USD 17.32 Billion by 2034.
The global general anxiety disorder treatment market is expected to grow at a CAGR of 3.8% during the forecast period.
North America is expected to dominate the general anxiety disorder treatment market over the forecast period.
Leading players in the global general anxiety disorder treatment market include Pfizer Inc., Merck & Co. Inc., AstraZeneca, GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, Johnson & Johnson, and H. Lundbeck A/S, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed